Acesso Biologics Announces Positive Real-World Data Demonstrating Robust Wound Closure Outcomes with Amniotic-Derived CAMPs
Las Vegas, Nevada — October 30, 2025 — Acesso Biologics today announced the publication of real-world registry data demonstrating the effectiveness of its amniotic-derived Cellular and Amniotic Membrane Products (CAMPs) in the treatment of multiple chronic wound types.
The study, published in the Biomed Journal of Scientific Read More